VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
1-Year Return
23.01%
This Quarter Return
-29.75%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$243M
AUM Growth
-$369M
(-60%)
Cap. Flow
-$185M
Cap. Flow
% of AUM
-76.23%
Top 10 Holdings %
Top 10 Hldgs %
9.9%
Holding
504
New
52
Increased
49
Reduced
307
Closed
94
Top Buys
| 1 |
Newmont
NEM
|
$1.82M |
| 2 |
COR
Coresite Realty Corporation
COR
|
$1.7M |
| 3 |
Public Storage
PSA
|
$1.53M |
| 4 |
Brookfield Renewable
BEP
|
$1.51M |
| 5 |
Avista
AVA
|
$1.44M |
Top Sells
| 1 |
Reliance Steel & Aluminium
RS
|
$4.3M |
| 2 |
Vale
VALE
|
$4.14M |
| 3 |
DEA
Easterly Government Properties
DEA
|
$4.07M |
| 4 |
NP
Neenah, Inc. Common Stock
NP
|
$4.04M |
| 5 |
Arbor Realty Trust
ABR
|
$3.91M |
Sector Composition
| 1 | Financials | 20.56% |
| 2 | Healthcare | 19.87% |
| 3 | Real Estate | 12.49% |
| 4 | Energy | 9.44% |
| 5 | Materials | 6.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Black Stone Minerals
BSM
$2.53B
| $606K | 0.25% |
129,569
-122,693
| -49% | -$574K |
|
152
Travere Therapeutics
TVTX
$1.93B
| $599K | 0.25% |
41,060
-3,465
| -8% | -$50.5K |
|
|
SGEN
153
DELISTED
Seagen Inc. Common Stock
SGEN
| $596K | 0.25% |
5,168
-436
| -8% | -$50.3K |
|
|
LRFC
154
DELISTED
Logan Ridge Finance Corp
LRFC
| $592K | 0.24% |
31,532
-10,959
| -26% | -$206K |
|
155
Omeros
OMER
$284M
| $587K | 0.24% |
43,917
-3,705
| -8% | -$49.5K |
|
156
OFS Capital
OFS
$117M
| $586K | 0.24% |
143,912
-38,881
| -21% | -$158K |
|
157
Moderna
MRNA
$9.78B
| $578K | 0.24% |
19,304
-2,829
| -13% | -$84.7K |
|
158
Amicus Therapeutics
FOLD
$2.46B
| $577K | 0.24% |
62,396
-5,265
| -8% | -$48.7K |
|
159
Exelixis
EXEL
$10.2B
| $569K | 0.23% |
33,024
-2,786
| -8% | -$48K |
|
160
EPR Properties
EPR
$4.05B
| $566K | 0.23% |
23,350
-23,488
| -50% | -$569K |
|
|
INN
161
Summit Hotel Properties
INN
$614M
| $564K | 0.23% |
133,628
-173,627
| -57% | -$733K |
|
162
Acadia Pharmaceuticals
ACAD
$4.26B
| $561K | 0.23% |
13,276
-1,120
| -8% | -$47.3K |
|
163
Bain Capital Specialty
BCSF
$1.02B
| $558K | 0.23% |
61,348
-7,776
| -11% | -$70.7K |
|
164
Halozyme
HALO
$8.76B
| $558K | 0.23% |
30,996
-2,616
| -8% | -$47.1K |
|
165
Investcorp Credit Management BDC
ICMB
$42.4M
| $551K | 0.23% |
226,348
-88,091
| -28% | -$214K |
|
166
Alnylam Pharmaceuticals
ALNY
$59.2B
| $544K | 0.22% |
5,002
-422
| -8% | -$45.9K |
|
167
PTC Therapeutics
PTCT
$4.55B
| $544K | 0.22% |
12,197
-1,029
| -8% | -$45.9K |
|
168
CEL-SCI Corp
CVM
$72.2M
| $536K | 0.22% |
1,548
-226
| -13% | -$78.3K |
|
|
ALXN
169
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $507K | 0.21% |
5,644
-457
| -7% | -$41.1K |
|
170
Amgen
AMGN
$153B
| $505K | 0.21% |
2,489
-210
| -8% | -$42.6K |
|
171
Nektar Therapeutics
NKTR
$764M
| $494K | 0.2% |
1,844
-156
| -8% | -$41.8K |
|
172
PhenixFIN
PFX
$98M
| $480K | 0.2% |
41,337
-13,683
| -25% | -$159K |
|
173
Delek Logistics
DKL
$2.31B
| $478K | 0.2% |
52,514
-60,920
| -54% | -$555K |
|
174
Oneok
OKE
$45.7B
| $476K | 0.2% |
21,808
-25,711
| -54% | -$561K |
|
175
Incyte
INCY
$16.9B
| $470K | 0.19% |
6,424
-543
| -8% | -$39.7K |
|